$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Detailed explanation of the mechanism of action of Tilorisen (Harcos) and its impact on the central arousal system
2026-02-01 22:25:32
Check Details
Pretomanid’s mechanism of action, pharmacological characteristics and scientific analysis of multi-drug-resistant tuberculosis treatment
2026-02-01 22:25:32
Check Details
Tepotinib produces better response in adenocarcinoma versus non-adenocarcinoma MET exon 14 skipped non-small cell lung cancer
2026-02-01 22:25:32
Check Details
Zanzalintinib plus atezolizumab versus regorafenib in previously treated metastatic colorectal cancer without MSI-H or dMMR tumors
2026-02-01 22:25:32
Check Details
What is the specific usage and dosage of pazopanib/vitant?
2026-02-01 22:25:32
Check Details
When will opicapone be launched in China?
2026-02-01 22:25:32
Check Details
How long does it take to take Fenelidone/Cashenda before you can consider stopping the drug?
2026-02-01 22:25:32
Check Details
Why it is necessary to control the dosage of rasagiline/alzilate
2026-02-01 22:25:32
Check Details
How much does a box of Pimitespib cost now in 2026?
2026-02-01 22:25:32
Check Details
What is the out-of-pocket price of Lynparza/Olaparib tablets in 2026?
2026-02-01 22:25:32
Check Details
What important information is included in the instructions for Platinib/Pujihua?
2026-02-01 22:25:32
Check Details
What is the daily dosage of capmatinib/touradida?
2026-02-01 22:25:32
Check Details
1
2
...
2457
2458
2459
2460
2461
2462
2463
...
10229
10230
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Elagolix for Endometriosis Pain: Indications and Usage Guidelines
2
Bosentan vs. Antihypertensives: What PAH Patients Need to Know
3
Letermovir: Proper Usage and Important Precautions
4
FDA Approves Daraxonrasib, Marking Milestone in Metastatic Pancreatic Cancer Treatment
5
Brensocatib for Non-Cystic Fibrosis Bronchiectasis: Patient Selection, ASPEN Data, and Safety Profile
6
Mirdametinib Mechanism and Clinical Guide: MEK Inhibitor for NF1 Plexiform Neurofibromas
7
FDA Approves Zanidatamab (Ziihera): HER2 Bispecific Antibody Plus Immunotherapy for First-Line Gastric Cancer
8
Acalabrutinib Dosing and Efficacy Guide: Administration, Response Evaluation, and Safety
9
Osimertinib Treatment and Dosing Guide: Efficacy, Administration, and Precautions
10
Bosutinib Indications Explained: CML Targeted Therapy and ADPKD Research Insights
11
Ceritinib Dosing Guide: 450mg Once Daily with Food – Key Administration Points
12
Ruxolitinib Drug Safety Guide: Drug Interactions, Hepatic/Renal Function, and Infection Risk Management